IL74680A - Immunosuppressant factor derived from human glioblastoma cells - Google Patents

Immunosuppressant factor derived from human glioblastoma cells

Info

Publication number
IL74680A
IL74680A IL74680A IL7468085A IL74680A IL 74680 A IL74680 A IL 74680A IL 74680 A IL74680 A IL 74680A IL 7468085 A IL7468085 A IL 7468085A IL 74680 A IL74680 A IL 74680A
Authority
IL
Israel
Prior art keywords
glioblastoma cells
human glioblastoma
factor derived
immunosuppressant
immunosuppressant factor
Prior art date
Application number
IL74680A
Other languages
English (en)
Other versions
IL74680A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP84810140A external-priority patent/EP0155433A1/en
Priority claimed from GB848429679A external-priority patent/GB8429679D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL74680A0 publication Critical patent/IL74680A0/xx
Publication of IL74680A publication Critical patent/IL74680A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Glass Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL74680A 1984-03-23 1985-03-21 Immunosuppressant factor derived from human glioblastoma cells IL74680A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP84810140A EP0155433A1 (en) 1984-03-23 1984-03-23 Immunosuppressant factor
GB848429679A GB8429679D0 (en) 1984-11-23 1984-11-23 Immunosuppressant factor

Publications (2)

Publication Number Publication Date
IL74680A0 IL74680A0 (en) 1985-06-30
IL74680A true IL74680A (en) 1988-11-30

Family

ID=26095665

Family Applications (1)

Application Number Title Priority Date Filing Date
IL74680A IL74680A (en) 1984-03-23 1985-03-21 Immunosuppressant factor derived from human glioblastoma cells

Country Status (12)

Country Link
EP (1) EP0159289B1 (da)
JP (1) JPH0680080B2 (da)
AT (1) ATE75778T1 (da)
AU (1) AU587973B2 (da)
CA (1) CA1341401C (da)
DE (1) DE3585968D1 (da)
DK (1) DK171600B1 (da)
IE (1) IE58821B1 (da)
IL (1) IL74680A (da)
NZ (1) NZ211525A (da)
WO (1) WO1985004421A1 (da)
ZA (1) ZA852194B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107465A (en) * 1984-12-21 2000-08-22 Otsuka Pharmaceutical Co., Ltd. IL-1β and derivatives thereof and drugs
DK172052B1 (da) * 1984-12-21 1997-09-29 Otsuka Pharma Co Ltd Antitumor-aktivt stof, fremgangsmåde til dets fremstilling, lægemiddel indeholdende stoffet, gen kodende for stoffet, vektor indeholdende genet samt rekombinant mikroorganisme transformet med en sådan vektor
US5342614A (en) * 1984-12-21 1994-08-30 Otsuka Pharmaceutical Co., Ltd. Method of treating arthritus or inflammation with IL-1β or derivatives thereof
US4886747A (en) * 1985-03-22 1989-12-12 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
US5284763A (en) * 1985-03-22 1994-02-08 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
US6586394B1 (en) 1985-04-19 2003-07-01 Osi Pharmaceuticals, Inc. Tissue-derived tumor growth inhibitor
US5008374A (en) * 1986-03-14 1991-04-16 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and drugs
JPS63126897A (ja) * 1986-05-02 1988-05-30 Yoshitomi Pharmaceut Ind Ltd 免疫抑制因子
PT86144B (pt) * 1986-11-17 1990-08-31 Sandoz Sa Processo para a preparacao de uma proteina tendo actividade semelhante a factor g-tsf humano e de composicoes farmaceuticas que o contem
US5221620A (en) * 1987-10-06 1993-06-22 Oncogen Cloning and expression of transforming growth factor β2
KR100196540B1 (ko) * 1988-11-04 1999-06-15 마틴 이. 샤브 축색성장 조절인자
CA1341050C (en) * 1988-11-04 2000-07-11 Martin E. Schwab Neurite growth regulatory factors
US5250414A (en) * 1988-11-04 1993-10-05 Erziehungsdirektion Of The Canton Zurich Diagnostic methods using neurite growth regulatory factors
WO1998046640A2 (en) * 1997-04-15 1998-10-22 Coulter International Corp. Methods and compositions for inducing immunosuppression
PL204293B1 (pl) 1998-11-06 2009-12-31 Univ Zuerich Oczyszczone białko i jego zastosowanie, izolowany kwas nukleinowy, wektor do klonowania, rekombinowana komórka, sposób wytwarzania rekombinowanego białka, sposób identyfikacji rybozymu lub antysensownego kwasu nukleinowego, przeciwciało monoklonalne, zastosowanie przeciwciała, sposób wytwarzania przeciwciał poliklonalnych, izolowana próbka surowicy odpornościowej, zastosowanie surowicy odpornościowej i sposób wytwarzania przeciwciał monoklonalnych.
CA2367132A1 (en) * 1999-03-24 2000-09-28 Gene M. Shearer Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (gcs)
US7101543B2 (en) 2000-03-31 2006-09-05 Novarx Genetically modified cells expressing a TGFβ inhibitor, the cells being lung cancer cells

Also Published As

Publication number Publication date
AU4157685A (en) 1985-11-01
JPS61501514A (ja) 1986-07-24
JPH0680080B2 (ja) 1994-10-12
IE850732L (en) 1985-09-23
DE3585968D1 (de) 1992-06-11
DK171600B1 (da) 1997-02-17
ATE75778T1 (de) 1992-05-15
DK539285D0 (da) 1985-11-21
CA1341401C (en) 2002-11-26
AU587973B2 (en) 1989-09-07
DK539285A (da) 1985-11-21
WO1985004421A1 (en) 1985-10-10
IE58821B1 (en) 1993-11-17
ZA852194B (en) 1986-11-26
EP0159289A1 (en) 1985-10-23
EP0159289B1 (en) 1992-05-06
IL74680A0 (en) 1985-06-30
NZ211525A (en) 1991-06-25

Similar Documents

Publication Publication Date Title
ZA852194B (en) Immunosuppressant factor
DE3869184D1 (de) Festelektrolyt-brennstoffzelle und zusammenbau.
GB2203138B (en) Shaped wood-based active carbon
DE3574579D1 (en) Platte.
NO167240C (no) Feste med flere frihetsgrader.
NO167122C (no) Implanterbar kneprotese.
EP0206424A3 (en) R.f. power amplifier
JPS6460373A (en) Human cells and trioner, antibody and trasformer derived from said cells
IT209301Z2 (it) Protesi uditiva.
IL87001A0 (en) Haloarylnitrile degrading gene,and cells containing the gene
GR3017451T3 (en) Peptides having T cell helper activity.
EP0215067A4 (en) Dental braces with adjustable function that can be manufactured in medical practice.
DE3888640D1 (de) Stromregler.
EP0113712A4 (en) POLYPEPTIDE FRACTION WITH IMMUNOSUPPRESSION ACTION.
DE3767752D1 (en) Elektrophotographische platte.
EP0216938A4 (en) CATALYST FOR HYDROTREATMENT.
GR851617B (da)
DE3673217D1 (de) Phenylalkyl-2,3-dihydrobenzofurane und analoga zur verwendung als antientzuendungsmittel.
DE69102115D1 (de) Bipolare Batterie und Zusammenbau-Methode.
EP0282501A4 (en) REGULATION OF ANIMAL REPRODUCTION.
DE3676632D1 (de) 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thione und ihre verwendung als antidepressiva.
EP0183780A4 (en) DIFFERENTIATION OF HUMAN CELLS.
NO851398L (no) Taakeleggingslegeme.
NO158988C (no) Intraokulaert implantat.
DE3680885D1 (de) 5-heterocyclisch substituierte-3h-1,2,4-triazol-3-thione und ihre verwendung als antidepressiva.

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
EXP Patent expired